09 marzo 2021 08:17
Fonte: Adnkronos
#salute-e-benessere
- - A survey of 1,165 biopharma executives and healthcare policymakers across 20 countries measured ability of industry to respond to global needs in five areas: Supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and government policy and regulation
- There is a strong correlation between higher performing countries and higher income per capita; United States leads the index overall but Switzerland and China have most resilient supply chains
- First such study to cover wide range of topics and respondents
AMERSHAM, United Kingdom, March 9, 2021 /PRNewswire/ Global life sciences leader Cytiva, along with the Financial Times research arm Longitude, have compiled a global index, ranking the ability of the biopharma industry to respond to five major challenges; in supply chain, talent, research and development, manufacturing, and government policy and regulation.
DETTINGEN AN DER ERMS (dpa-AFX) - ElringKlinger AG (EGKLF.PK) announced Tuesday that it has bagged a high-volume order for the supply of battery components the German plant of a global battery